Publication Title |
Federal Register Volume
75, Issue 171
(September 3, 2010)
|
Category | Regulatory Information |
Collection | Federal Register |
SuDoc Class Number | AE 2.7: GS 4.107: AE 2.106: |
Publisher | Office of the Federal Register, National Archives and Records Administration |
Section | Rules and Regulations |
Action | Final rule. |
Dates | This rule is effective September 3, 2010. |
Contact | Suzanne J. Sechen, Center for Veterinary Medicine (HFV-126), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 240-276-8105, e-mail: suzanne.sechen@fda.hhs.gov. |
Summary | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of two supplemental new animal drug applications (NADAs) filed by Elanco Animal Health, A Division of Eli Lilly & Co. The supplemental NADAs provide for administering a Type C medicated feed containing ractopamine hydrochloride as a top dress on Type C medicated feeds containing monensin, USP, or monensin, USP, and tylosin phosphate to cattle fed in confinement for slaughter. |
Agency Names | DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration |
Page Number Range | 54019-54020 |
Federal Register Citation | 75
FR
54019 |
CFR Citation | 21
CFR
558 |
Docket Numbers | Docket No. FDA-2010-N-0002 |
FR Doc Number | 2010-22071 |
|
This is part of
Federal Register Volume
75, Issue 171
(September 3, 2010)
|
| View Entire Issue |
|